Free Trial
Notice: This company has been marked as potentially delisted and may not be actively trading.

Natus Medical (NTUS) News Today

Natus Medical logo
Natus Medical Incorporated
Natus Medical Incorporated stock logo
Natus Medical (NASDAQ:NTUS) Upgraded to "Strong-Buy" at StockNews.com
StockNews.com raised shares of Natus Medical from a "buy" rating to a "strong-buy" rating in a research note on Friday.
Natus Medical Incorporated stock logo
Natus Medical Incorporated (NASDAQ:NTUS) Sees Significant Growth in Short Interest
Natus Medical Incorporated (NASDAQ:NTUS - Get Rating) was the recipient of a large growth in short interest in the month of June. As of June 15th, there was short interest totalling 1,600,000 shares, a growth of 36.8% from the May 31st total of 1,170,000 shares. Approximately 4.7% of the company's shares are short sold. Based on an average daily trading volume, of 512,200 shares, the days-to-cover ratio is presently 3.1 days.
Natus Medical Incorporated stock logo
StockNews.com Lowers Natus Medical (NASDAQ:NTUS) to Buy
StockNews.com cut shares of Natus Medical from a "strong-buy" rating to a "buy" rating in a research note on Saturday.
Natus Medical Incorporated stock logo
Natus Medical (NASDAQ:NTUS) Upgraded to Strong-Buy at StockNews.com
StockNews.com upgraded Natus Medical from a "buy" rating to a "strong-buy" rating in a report on Friday.
Natus Medical Incorporated stock logo
Natus Medical Incorporated (NASDAQ:NTUS) Short Interest Up 57.2% in May
Natus Medical Incorporated (NASDAQ:NTUS - Get Rating) was the recipient of a significant growth in short interest in the month of May. As of May 15th, there was short interest totalling 1,090,000 shares, a growth of 57.2% from the April 30th total of 693,400 shares. Based on an average daily trading volume, of 440,300 shares, the short-interest ratio is presently 2.5 days. Approximately 3.2% of the company's stock are short sold.
Natus Medical Incorporated stock logo
Natus Medical (NASDAQ:NTUS) Issues Quarterly Earnings Results, Misses Expectations By $0.04 EPS
Natus Medical (NASDAQ:NTUS - Get Rating) released its earnings results on Thursday. The company reported $0.22 earnings per share for the quarter, missing the consensus estimate of $0.26 by ($0.04). Natus Medical had a net margin of 2.78% and a return on equity of 9.75%. During the same quarter in the prior year, the business posted $0.16 EPS.
Natus Medical Incorporated stock logo
Zacks Investment Research Lowers Natus Medical (NASDAQ:NTUS) to Hold
Zacks Investment Research downgraded Natus Medical from a "buy" rating to a "hold" rating in a research note on Tuesday.
Natus Medical Incorporated stock logo
Natus Medical (NASDAQ:NTUS) Lifted to "Buy" at Zacks Investment Research
Zacks Investment Research upgraded Natus Medical from a "hold" rating to a "buy" rating and set a $30.00 target price for the company in a research report on Thursday.
Natus Medical: Q4 Earnings Insights
Natus Medical: Q4 Earnings Snapshot
Get Natus Medical News Delivered to You Automatically

Sign up to receive the latest news and ratings for NTUS and its competitors with MarketBeat's FREE daily newsletter.

Sell NVDA Now? (Ad)

Guess who's selling NVDA next The most successful hedge fund in history quietly sold 500,000 shares. Here's what that means for your money. Billionaire Wall Street investors are quietly offloading millions of shares. What do they know that you don't? It's arguably the most popular stock in the world. Now, one 50-year Wall Street legend says its day in the sun could finally be coming to an end. Last year, he warned of two stocks that went on to crash 60%.

Now he's just issued a warning for the most popular stock in the world: Nvidia (NVDA).

NTUS Media Mentions By Week

NTUS Media Sentiment

Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press.

NTUS
News Sentiment

0.59

0.43

Average
Medical
News Sentiment

NTUS News Coverage

We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week.

NTUS Articles
This Week

0

1

NTUS Articles
Average Week

Get Natus Medical News Delivered to You Automatically

Sign up to receive the latest news and ratings for NTUS and its competitors with MarketBeat's FREE daily newsletter.


Related Companies and Tools


This page (NASDAQ:NTUS) was last updated on 11/2/2024 by MarketBeat.com Staff
From Our Partners